Growth Metrics

Alx Oncology Holdings (ALXO) Other Working Capital Changes (2019 - 2026)

Alx Oncology Holdings' Other Working Capital Changes history spans 5 years, with the latest figure at -$3.0 million for Q4 2023.

  • On a quarterly basis, Other Working Capital Changes fell 3610.47% to -$3.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.3 million, a 272.13% increase, with the full-year FY2025 number at -$658000.0, up 68.23% from a year prior.
  • Other Working Capital Changes hit -$3.0 million in Q4 2023 for Alx Oncology Holdings, down from $4.8 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ALXO hit a ceiling of $8.7 million in Q2 2021 and a floor of -$7.0 million in Q3 2021.
  • Historically, Other Working Capital Changes has averaged $99777.8 across 5 years, with a median of -$70500.0 in 2019.
  • The widest YoY moves for Other Working Capital Changes: up 8198.15% in 2021, down 5465.38% in 2021.
  • Tracing ALXO's Other Working Capital Changes over 5 years: stood at -$384000.0 in 2019, then soared by 103.91% to $15000.0 in 2020, then plummeted by 2773.33% to -$401000.0 in 2021, then soared by 121.45% to $86000.0 in 2022, then plummeted by 3610.47% to -$3.0 million in 2023.
  • Business Quant data shows Other Working Capital Changes for ALXO at -$3.0 million in Q4 2023, $4.8 million in Q3 2023, and -$318000.0 in Q2 2023.